Arsen V. Osipov - Publications

Development and Validation of a Computational Histology Artificial Intelligence-Powered Predictive Biomarker for Selection of Chemotherapy in Advanced Pancreatic Cancer.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: February 11, 2026

L-Glutamine in combination with first-line gemcitabine and nab-paclitaxel in advanced pancreatic ductal adenocarcinoma: an open-label, single-arm, phase 1 GlutaPanc trial.

Journal: Nature cancer

Published: December 30, 2025

Recurrence in Patients With Lymph Node-Negative Pancreatic Neuroendocrine Tumors.

Journal: JAMA surgery

Published: December 17, 2025

Circulating Tumor Cells as the Liquid Biopsy Foray into Noninvasive Colorectal Cancer Screening.

Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Published: December 08, 2025

Next-Generation Sequencing of Multivergent Morphologies in Colorectal Carcinomas Identifies Unique Targetable Alterations.

Journal: The American journal of surgical pathology

Published: November 05, 2025

Implications of Homologous Recombination Deficiency for Neoadjuvant Platinum-Based Chemotherapy in Pancreatic Cancer: A Narrative Review.

Journal: Annals of surgical oncology

Published: October 28, 2025

Pathogenic germline variants identified in pNEN patients during genetic testing.

Journal: Endocrine oncology (Bristol, England)

Published: October 03, 2025

Evaluating the Effect of KRAS Variants on Survival Outcomes and Therapy Response in Pancreatic Cancer.

Journal: JCO precision oncology

Published: August 20, 2025

Pan-cancer prediction of tumor immune activation and response to immune checkpoint blockade from tumor transcriptomics and histopathology.

Journal: bioRxiv : the preprint server for biology

Published: August 01, 2025

The evolving role of ctDNA in colorectal cancer: guidance of adjuvant therapy or surveillance strategies?

Journal: Translational gastroenterology and hepatology

Published: June 17, 2025

Tumor Treating Fields With Gemcitabine and Nab-Paclitaxel for Locally Advanced Pancreatic Adenocarcinoma: Randomized, Open-Label, Pivotal Phase III PANOVA-3 Study.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: May 31, 2025

The combination of a cancer vaccine, pembrolizumab, and stereotactic body radiation in patients with locally advanced pancreatic cancer: a single-arm, phase II study.

Journal: Nature communications

Published: April 24, 2025